The trademark application ALTRUBIO was filed by AltruBio Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 30, 2022, and it was registered by office on September 6, 2022 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for use in the treatment of immunoregulatory diseases, inflammatory diseases, autoimmune diseases and cancers and diagnostic preparations for clinical or medical laboratory purposes..
The mark was filed in class 42 with following description of goods:
Biological product research and development services
Consultation in the field of biological product research